Bhubaneswar: Remdesivir, the anti-viral drug that can potentially treat COVID-19, has reached Odisha today, informed the State Health dept additional chief secretary Pradipta Mohapatra.
The drug will now be used for critical COVID-19 patients undergoing treatment at COVID hospitals in the state, the official added.
The drug is available in 100 mg vials (injectable). It needs to be administered intravenously in a hospital, critical care setting, under the supervision of a registered medical practitioner.
The maximum retail price has been fixed at Rs 5,400 per vial for the drug.
Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.
Remdesivir was approved on June 1 under emergency use with condition for five dose administration.